Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

Human Gene Therapy

Volumn 11, Issue 11, 2000, Pages 1569-1576

  Qiao, J ^a   Black, M E ^b   Caruso, M ^a  

^a LAVAL UNIVERSITY   (Canada)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MUTANT; NONHUMAN; RETROVIRUS;

ANTIVIRAL AGENTS; GANCICLOVIR; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HT29 CELLS; HUMANS; MUTAGENESIS; RECOMBINATION, GENETIC; RETROVIRIDAE; RNA; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

HERPES; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0034691509     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050083298     Document Type: Article

References (42)

1. Thymidine kinase-mediated killing of rat brain tumors
2. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
3. The thymidine kinase/ganciclovir-mediated 'suicide' effect is variable in different tumor cells
4. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
5. Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: Analysis of selected mutants in vitro
6. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy
7. Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase
8. Exchange between hamster cells in culture
9. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
10. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells
11. High-titer packaging cells producing recombinant retroviruses resistant to human serum
12. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
13. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes
14. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo
15. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro
16. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
17. The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells
18. Prodrug-activated gene therapy: Involvement of an immunological component in the 'bystander effect'
19. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer
20. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
21. Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
22. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy
23. Gene therapy in brain tumours: Implications of the size of glioblastoma on its curability
24. A phase I/II study of herpes simplex virus type 1 thymidine kinase 'suicide' gene therapy for recurrent glioblastoma
25. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant
26. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy
27. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
28. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
29. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
30. Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V)
31. The discovery of metabolic co-operation
32. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
33. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
34. In vivo analysis of the 'bystander effect': A cytokine cascade
35. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells
36. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells
37. 'Bystander killing' induces apoptosis and is inhibited by forskolin
38. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
39. Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: Implications for gene therapy
40. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
41. Generation of an anti-tumor immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression
42. S- and G2-phase cell cycle arrest and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase